News & Analysis as of

Office of the Inspector General Drug Compounding

King & Spalding

OIG Reports Lack of Oversight on Hospital Use of Compounded Drugs

King & Spalding on

On January 22, 2015, the HHS OIG released a report regarding CMS’s oversight of compounded sterile preparations (CSPs) used in hospitals. After reviewing oversight efforts at CMS and the entities that accredit hospitals to...more

BakerHostetler

Compounded Drugs and Medicare Part B: OIG Report Recommends Payment and Oversight Changes

BakerHostetler on

The Office of the Inspector General (OIG) for HHS recently published a report titled “Compounded Drugs Under Medicare Part B: Payment and Oversight” (OIG Report) in which it recommended that CMS implement changes to the way...more

Williams Mullen

OIG 2014 Work Plan Focuses On Compounded Pharmaceuticals Reimbursed By Medicare

Williams Mullen on

The Office of Inspector General for the U.S. Department of Health and Human Services (“OIG”) included two items in its recently-released 2014 Work Plan indicating a new focus on the quality and safety of compounded...more

3 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide